Novartis AG (NYSE:NVS)

87.36
Delayed Data
As of Nov 29
 -0.32 / -0.36%
Today’s Change
74.09
Today|||52-Week Range
94.26
-0.13%
Year-to-Date
Incyte (INCY) Outperforms YTD: Will the Momentum Continue?
Nov 25 / Zacks.com - Paid Partner Content
2 Top Biotech Stocks to Buy Right Now
Nov 19 / MotleyFool.com - Paid Partner Content
Novartis (NVS) Set to Advance Malaria Drug Into Phase III
Nov 24 / Zacks.com - Paid Partner Content
Novartis (NVS) Reportedly Looking to Sell Its Business Units
Nov 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close87.68
Today’s open87.76
Day’s range87.28 - 88.01
Volume1,403,834
Average volume (3 months)2,240,423
Market cap$188.7B
Data as of 4:00pm ET, 11/29/2022

Growth & Valuation

Earnings growth (last year)+202.15%
Earnings growth (this year)-4.57%
Earnings growth (next 5 years)+4.06%
Revenue growth (last year)+6.10%
P/E ratio9.0
Price/Sales3.83
Price/Book2.90

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.13-0.19%
NVONovo Nordisk+0.12+0.10%
BMYBristol-Myers Squibb-0.16-0.20%
SNYSanofi+0.33+0.72%
Data as of 4:00pm ET, 11/29/2022

Financials

Next reporting dateFebruary 1, 2023
EPS forecast (this quarter)$1.37
Annual revenue (last year)$51.6B
Annual profit (last year)$24.0B
Net profit margin46.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts